HS135
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HS135, covering 2025-05-30 to 2025-09-04. Get the full timeline:
Most recent: Clinical Trial Update: Study of HS135 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction [Phase 1]